leyuÀÖÓÚ

1 ÊܽÌÓýÇé¿ö (1)2011.9¨C2014.6, ÄÏ·½Ò½¿Æ´óѧҩѧԺ, Ò©Àíѧ, ²©Ê¿, µ¼Ê¦: ÁõÖÐÇï

(2)2008.9¨C2011.6, ºÓÄÏ´óѧҩѧԺ, Ö×ÁöÒ©Àíѧ, ˶ʿ, µ¼Ê¦: ¶Å¸Ö¾ü

(3)2004.9¨C2008.6, ºÓÄÏ´óѧҩѧԺ, Ò©ÎïÖƼÁ, ѧʿ

2 ¿ÆÑй¤×÷¾­Àú 1)2016.1-ÖÁ½ñ, leyuÀÖÓÚ, ¹ú¼ÊÖÐҽҩת»¯Ò½Ñ§leyuÀÖÓÚËù, leyuÀÖÓÚÔ±

2)2015.4-2015.10, ÃÀ¹úÂÞ¸ñ˹ÐÂÔóÎ÷ÖÝÁ¢´óѧ, ҩѧԺ, ·ÃÎÊѧÕß

3)2014.7-2015.12, leyuÀÖÓÚ, ¹ú¼ÊÖÐҽҩת»¯Ò½Ñ§leyuÀÖÓÚËù, ½²Ê¦

4)2013.5-2014.5, ÃÀ¹úÍþ˹¿µÐÇҽѧԺ, Ö×ÁöÖÐÐÄ, ·ÃÎÊѧÕß

1£©ÖÐÒ©¼°Æä»îÐԳɷÖÔ¤·À¼°ÖÎÁÆÖ×ÁöµÄ×÷Óü°·Ö×Ó»úÖÆ£»

2£©ÖÐÒ©Ò©´ú¶¯Á¦Ñ§·Ö×Óµ÷¿Ø¼°¸öÌ廯ÓÃÒ©

[1]¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÓÅÐãÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬ÖÐÒ©Ò©´ú¶¯Á¦Ñ§·Ö×Óµ÷¿Ø¼°¸öÌ廯ÓÃÒ©£¬ÏîÄ¿±àºÅ£º82022074£¬ 2021/1/1-2023/12/31£¬120ÍòÔª£¬ÔÚÑÐ

[2]¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬É½ÄηӵÄϸ°ûºËÄÚ´¦Öõ÷¿ØDNA¼×»ùתÒÆøÒÖÖƽ᳦°©·Ö×Ó»úÖƼ°¶ÔÖÐҩɽÄÎҩЧµÄÓ°Ï죬ÏîÄ¿±àºÅ£º81874367£¬2019/01/01 - 2022/12/31£¬59ÍòÔª£¬ÔÚÑÐ

[3]¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬ºËÊÜÌå½éµ¼µÄCYP3AºÍÍâÅÅתÔ˵°°×ÔÚ¸½×Ó¸öÌ廯ÓÃÒ©ÖеÄ×÷Óü°»úÖÆ£¬ÏîÄ¿±àºÅ£º 81503466£¬2016/01/01-2018/12/31£¬21.6ÍòÔª£¬½áÌâ

[4]¹ã¶«Ê¡½Ü³öÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬ÖÐÒ©¸öÌ徫׼ÓÃÒ©µÄÒ©´ú¶¯Á¦Ñ§»ù´¡£¬ÏîÄ¿±àºÅ£º2017A030306033£¬2017/05/01 - 2021/05/01£¬100ÍòÔª£¬ÔÚÑÐ

[5]¹ãÖÝÊпƼ¼´´ÐÂίԱ»á2017Äê¹ãÖÝÊÐÖé½­¿Æ¼¼ÐÂÐÇ£¬È·ÓÐÁÆЧÓж¾ÖÐÒ©¸½×Ó¸öÌ廯¾«×¼ÓÃÒ©µÄÒ©´ú¶¯Á¦Ñ§»ù´¡¼°µ÷¿Ø»úÖÆ£¬ÏîÄ¿±àºÅ£º201710010108£¬2017/05/01-2020/04/30£¬30ÍòÔª£¬½áÌ⣬Ö÷³Ö

[6]¹ã¶«Ê¡½ÌÓýÌüÖƹ㶫ʡÆÕͨ¸ßУÌØÉ«´´ÐÂÏîÄ¿£¬ÖÐÒ©¾«×¼¸öÌ廯ÓÃÒ©µÄÒ©´ú¶¯Á¦Ñ§µ÷¿Ø»úÖÆ£¬ÏîÄ¿±àºÅ£º2016KTSCX012£¬2017/01/01-2018/12/31£¬10ÍòÔª£¬½áÌâ

[7]¹ã¶«Ê¡½ÌÓýÌü£¬2016Äê¹ã¶«Ê¡¸ßµÈѧУÇàÄêÖ齭ѧÕߣ¬ 2016/10/01-2019/10/01£¬100ÍòÔª£¬½áÌâ

[1] Guo YJ, Yao JJ, Guo ZZ, Ding M, Zhang KL, Shen QH, Li Y, Yu SF, Wan T, Xu FP, Wang Y, Qi XX, Wu JJ, Chen JX, Liu ZQ, Linlin Lu*£¨Â¬ÁÕÁÕ, ͨѶ×÷Õߣ©. HBB contributes to individualized aconitine-induced cardiotoxicity in mice via interfering with ABHD5/AMPK/HDAC4 axis. Acta Pharmacol Sin. 2024 Jun;45(6):1224-1236. Epub 2024 Mar 11.£¨2024 IF: 6.9£»5-year IF: 7.6; ÖпÆÔº·ÖÇø: 1Çø£©

[2] Li JM, Deng HS, Yao YD, Wang WT, Hu JQ, Dong Y, Wang PX, Liu L, Liu ZQ, Xie Y*, Lu LL* (¬ÁÕÁÕ£¬¹²Í¬Í¨Ñ¶×÷Õß), Zhou H*. Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways. Acta Pharmacol Sin. 2023 Jul 24. doi: 10.1038/s41401-023-01124-4. Epub ahead of print. PMID: 37482570.£¨2023 IF: 6.9£»5-year IF: 7.6; ÖпÆÔº·ÖÇø: 1Çø£©

[3] Su T#, Huang SC#, Zhang YM, Guo YJ, Zhang SW, Guan JJ, Meng MJ, Liu LX, Wang CY, Yu DH, Hiu-Yee Kwanc, Huang ZY, Huang QJ, Elaine Lai-Han Leung, Hu M, Wang Y, Liu ZQ*, Lu LL*£¨Â¬ÁÕÁÕ£¬Í¨Ñ¶×÷Õߣ©miR-7/TGF-b2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis.Acta Pharmaceutica Sinica B.2021.06.009. £¨2021 IF: 14.9£»5-year IF: 14.1; ÖпÆÔº·ÖÇø: 1Çø£©

[4] Wang WS# , Huang QJ#, Chen Y, Huang ZY, Huang YF, Wang Y, Qi XX, Liu ZQ* , Lu LL*£¨Â¬ÁÕÁÕ£¬Í¨Ñ¶×÷Õߣ©.The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.Pharmacological Research. 2021 Aug;170:105723. 7.658£¨2021 IF: 10.3£»5-year IF: 9; ÖпÆÔº·ÖÇø: 1Çø£©

[5] YangX#, ZhangYM, HuangYF, WangY, QiXX, SuT*, LuLL*£¨Â¬ÁÕÁÕ£¬Í¨Ñ¶×÷Õߣ©. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to ¦Ã-secretases. Phytomedicine. 2020 Mar;68:153176.£¨2020 IF: 5.3£»5-year IF: 6.3; ÖпÆÔº·ÖÇø: 1Çø£©

¿ÆÑн±ÀøÇé¿ö

[1] »ùÓÚÉúÎïÀûÓöÈÆÁÕϵÄÖÐÒ©¼°¸´·½¹¦Ð§ÆÀ¼Û·½·¨µÄ´´Ð¼°Ó¦Óã¬2019Äê¹ã¶«Ê¡¿Æ¼¼½ø²½½±Ò»µÈ½±£¬ÅÅÃû£º3/15¡£

[2] 2019 Äê, ¡°DACT2 Epigenetic Stimulator Exerts Dual Efficacy for Colorectal Cancer Prevention and Treatment. Volume 129, (2018). Pages 318-328.¡±, 2018/2019 Äê¶ÈÁÁµãÂÛÎÄ, Pharmacological Research, ELSEVIER. ÅÅÃûµÚ1λ¡£

[3] 2019Ä꣬ÏãÇàÀ¼»Æͪ¿Ú·þÉúÎïÀûÓöÈÆÁÕÏ·Ö×Ó»úÖƼ°Ðļ¡±£»¤×÷ÓûúÖƵÄleyuÀÖÓÚ£¬Ð½®Éú²ú½¨Éè±øÍÅ¿Æѧ¼¼Êõ½±ÀøÖ¤Êé¶þµÈ½±£¬ÅÅÃû£º5/10¡£

[4] ÒÖÖÆϸ°ûÔöÖ³Óë·Ö»¯Òì³£µÄлúÖÆleyuÀÖÓÚ£¬2018Äê¶È½ÌÓý²¿¸ßµÈѧУ¿ÆѧÑÐ] ¾¿ÓÅÐã³É¹û×ÔÈ»¿Æѧ½±Ò»µÈ½±£¬ÅÅÃû£º15/15¡£

[5] 2018Ä꣬µÚ¶þÊ®¶þ½ìÖйúÒ©Àíѧ»áʩάÑÅÇàÄêÒ©Àíѧ¼Ò½±£¬»ñ½±ÈË£ºÂ¬ÁÕÁÕ¡£ÅÅÃûµÚ1λ¡£

´ú±íÐÔÂÛÎÄ

[1] ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬¸½×ÓÎÚÍ·ÀàÉúÎï¼îÌØÒìÐÔ°ÐÏòÓÎÀëÐÍѪºìµ°°×¦ÂÁ´ÓÕ·¢ÐÄÔ඾ÐԵġ°¹¹-Ïó-Á¿-¶¾¡±¹Øϵ¼°S-ÑÇÏõ»ù»¯µ÷¿Ø»úÖÆ£¬ÏîÄ¿±àºÅ£º82274196£¬2023/1/1-2026/12/31£¬52ÍòÔª£¬ÔÚÑÐ

[2] ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÓÅÐãÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬ÖÐÒ©Ò©´ú¶¯Á¦Ñ§·Ö×Óµ÷¿Ø¼°¸öÌ廯ÓÃÒ©£¬ÏîÄ¿±àºÅ£º82022074£¬2021/1/1-2023/12/31£¬120ÍòÔª£¬½áÌâ

[3] ÖÐÒ½Ò©¹ã¶«Ê¡ÊµÑéÊÒ£¨ºáÇÙʵÑéÊÒ£©¿Æ¼¼Ñз¢ÅàÖ²ÏîÄ¿£¬Ò©Ê³Í¬Ô´ÖÐҩͨ¹ýµ÷¿Ø³¦µÀÁÜ°ÍפÁô¾úÒÖÖÆÔçÆÚ½áÖ±³¦°©Ñ×°©×ª»¯¼°·Ö×Ó»úÖÆ£¬ÏîÄ¿ºÅ±àºÅ£ºHQL2024PZ040£¬2024.09.01-2026.09.01,100ÍòÔª£¬ÔÚÑÐ

[4] Ê¡²¿¹²½¨ÖÐҽʪ֤¹ú¼ÒÖصãʵÑéÊÒ£¬ÊªÖ¢´úл×ÛºÏÕ÷µÄ±í¹ÛÒÅ´«Ñ§°Ð±ê·¢ÏÖ¼°·Ö×Ó»úÖƺÍÓ¦Óã»ÏîÄ¿ºÅ±àºÅ£ºSZ2022KF09£¬2023.01-2025.01£¬50ÍòÔª£¬ÔÚÑÐ

[5] ¹ã¶«Ê¡½Ü³öÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬ÖÐÒ©¸öÌ徫׼ÓÃÒ©µÄÒ©´ú¶¯Á¦Ñ§»ù´¡£¬ÏîÄ¿±àºÅ£º2017A030306033£¬2017/05/01 - 2022/05/01£¬100ÍòÔª£¬½áÌâ